clopidogrel has been researched along with Angina Pectoris, Variant in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baek, SH; Cho, SS; Gwon, HC; Han, SH; Her, SH; Jo, SH; Kim, SE; Lee, BK; Lee, KY; Lee, MH; Park, KH; Rha, SW; Seo, WW; Suh, JW; Yang, TH | 1 |
Giliarov, MIu; Malova, EV; Novikova, NA; Sulimov, VA; Syrkin, AL | 1 |
1 trial(s) available for clopidogrel and Angina Pectoris, Variant
Article | Year |
---|---|
[Effectiveness and safety of clopidogrel bisulfate in complex therapy of patients with acute coronary syndrome with ST segment elevation].
Topics: Acute Disease; Angina Pectoris, Variant; Clopidogrel; Echocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Syndrome; Ticlopidine; Treatment Outcome | 2006 |
1 other study(ies) available for clopidogrel and Angina Pectoris, Variant
Article | Year |
---|---|
Clopidogrel plus Aspirin Use is Associated with Worse Long-Term Outcomes, but Aspirin Use Alone is Safe in Patients with Vasospastic Angina: Results from the VA-Korea Registry, A Prospective Multi-Center Cohort.
Topics: Aged; Angina Pectoris, Variant; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Republic of Korea; Treatment Outcome | 2019 |